Exact Mass: 359.84722659999994

Exact Mass Matches: 359.84722659999994

Found 19 metabolites which its exact mass value is equals to given mass value 359.84722659999994, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Haloprogin

1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene

C9H4Cl3IO (359.8372494)


Haloprogin is used as a topical ointment or cream in the treatment of Tinea infections. Tinea infections are superficial fungal infections caused by three species of fungi collectively known as dermatophytes (Trichophyton, Microsporum and Epidermophyton). Commonly these infections are named for the body part affected, including tinea corporis (general skin), tinea cruris (groin), and tinea pedis (feet). Haloprogin is a halogenated phenolic ether administered topically for dermotaphytic infections. The mechanism of action is unknown, but it is thought to be via inhibition of oxygen uptake and disruption of yeast membrane structure and function. D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

(1Z,3E,5S,6R,7E)-1,8-dibromo-5,6-dichloro-2,6-dimethyl-octa-1,3,7-triene

(1Z,3E,5S,6R,7E)-1,8-dibromo-5,6-dichloro-2,6-dimethyl-octa-1,3,7-triene

C10H12Br2Cl2 (359.8682732)


   
   

Haloprogin

1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene

C9H4Cl3IO (359.8372494)


D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

3,5-Diiodobenzyl alcohol

3,5-Diiodobenzyl alcohol

C7H6I2O (359.8508166)


   

3,5-diiodo-6-methylpyridin-2-amine

3,5-diiodo-6-methylpyridin-2-amine

C6H6I2N2 (359.8620496)


   

2,6-DIIODO-P-BENZOQUINONE

2,6-DIIODO-P-BENZOQUINONE

C6H2I2O2 (359.8144332)


   

sodium tetrachloroaurate

sodium tetrachloroaurate

AuCl4Na (359.831742)


   

1,4-dibromo-2,3-difluoro-5,6-dinitrobenzene

1,4-dibromo-2,3-difluoro-5,6-dinitrobenzene

C6Br2F2N2O4 (359.8192864)


   

diosMectite

Montmorillonite

Al2H2O12Si4 (359.82542320000005)


A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07B - Intestinal adsorbents C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D020011 - Protective Agents > D000931 - Antidotes Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

4,6-diiodobenzene-1,3-diamine

4,6-diiodobenzene-1,3-diamine

C6H6I2N2 (359.8620496)


   

mercuric bromide

mercuric bromide

Br2Hg (359.807304)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants > D001965 - Bromides

   

2,3,5-Tribromo-N,N-dimethyl-4-pyridinamine

2,3,5-Tribromo-N,N-dimethyl-4-pyridinamine

C7H11Br3N2 (359.84722659999994)


   

Bonefos

Bonefos

CH10Cl2Na2O10P2 (359.892168)


C78275 - Agent Affecting Blood or Body Fluid > C2136 - Malignancy-Associated Hypercalcemia Inhibitor C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates

   

(1z,3e,5r,6r,7e)-1,8-dibromo-5,6-dichloro-2,6-dimethylocta-1,3,7-triene

(1z,3e,5r,6r,7e)-1,8-dibromo-5,6-dichloro-2,6-dimethylocta-1,3,7-triene

C10H12Br2Cl2 (359.8682732)


   

(1z,3e,5s,6r,7z)-1,8-dibromo-5,6-dichloro-2,6-dimethylocta-1,3,7-triene

(1z,3e,5s,6r,7z)-1,8-dibromo-5,6-dichloro-2,6-dimethylocta-1,3,7-triene

C10H12Br2Cl2 (359.8682732)